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Abstract
We studied the occurrence of adverse events (AEs) in low-risk non-survivors (LNs), compared to low-risk survivors
(LSs), high-risk non-survivors (HNs), and high-risk survivors (HSs) in two pediatric intensive care units (PICUs).
The study was performed as a retrospective patient record review study, using a PICU-trigger tool. A random sample
of 48 PICU patients (0–18 years) was chosen, stratified into four subgroups of 12 patients: LNs, LSs, HNs, and
HSs. Primary outcome was the occurrence of AEs. The severity, preventability, and nature of the indentified AEs
were determined. In total, 45 AEs were found in 20 patients. The occurrence of AEs in the LN group was
significantly higher compared to that in the LS group and HN group (AE occurrence: LN 10/12 patients, LS 1/12
patients; HN 2/12 patients; HS 7/12 patients; LN-LS difference, p < 0.001; LN-HN difference, p < 0.01). The AE rate
in the LN group was significantly higher compared to that in the LS and HN groups (median [IQR]: LN 0.12 [0.07–
0.29], LS 0 [0–0], HN 0 [0–0], and HS 0.03 [0.0–0.17] AE/PICU day; LN-LS difference, p < 0.001; LN-HN
difference, p < 0.01). The distribution of the AEs among the four groups was as follows: 25 AEs (LN), 2 AEs
(LS), 8 AEs (HN), and 10 AEs (HS). Fifteen of forty-five AEs were preventable. In 2/12 LN patients, death
occurred after a preventable AE.
Conclusion: The occurrence of AEs in LNs was higher compared to that in LSs and HNs. Some AEs were severe and
preventable and contributed to mortality.
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What is Known:
• 59–76% of all PICU patients encounter at least one adverse event during their PICU stay.
• It is unknown if adverse events play a role in death of low-risk PICU patients.
What is New:
• In low-risk PICU non-survivors, occurrence of adverse events is higher compared to low-risk PICU survivors and to high-risk PICU non-survivors.
• Severe and preventable adverse events occur in low-risk PICU non-survivors, some contributing to mortality.




CCC Complex chronic condition






NCCC Non-complex chronic condition
N C C
MERP
National Coordinating Council for Medication
Error Reporting and Prevention
PICU Pediatric intensive care unit
PIM Pediatric Index of Mortality
PRISM Pediatric Risk of Mortality
Introduction
Themortality rate in the pediatric intensive care unit (PICU) in
economically developed countries has decreased in the last
decades to approximately 3% [26]. Moreover, a substantial
part of the PICU population (55% in a recent study) has a
mortality risk of < 1% [35]. Although these are low-risk pa-
tients, some of these patients die on the PICU. Patient factors
like complex chronic conditions (CCCs) do not explain all
deceased patients in this patient group [6, 35]. For quality
purposes, it is interesting to analyze whether adverse events
(AEs) or even medical errors play a role in the death of low-
risk PICU patients [3, 16]. An AE is an unintended injury that
results in temporary or permanent disability, death, or
prolonged hospital stay and that is caused by health care man-
agement rather than by the patient’s underlying disease pro-
cess [38]. A national project on preventable deaths in Dutch
hospitals showed that preventable AEs contributed to 4.1% of
hospital deaths [38, 39]. In most international AE studies,
(young) children were excluded or the number of included
PICU admissions was not specified or very low, so data about
PICU patients are scarce [2–4, 18, 38].
Because of their vulnerability, intensive care patients are
more prone to iatrogenic events [10, 12, 13]. The incidence of
AEs in the PICU population depends on the method used to
detect AEs [1, 17, 19, 22, 28, 31, 33, 36]. Studies using a
trigger tool method show that 59–76% of all PICU patients
encounter at least one AE during their stay [1, 17, 36].
Although one could speculate that AE incidence is
higher in the more complex and sicker patients needing
extensive support (high-risk patients), AEs also occur in
the less severely ill PICU patients [1, 17, 22]. To our
knowledge, no studies have focused on the occurrence
of AEs in low-risk PICU patients. The incidence of AEs
among low-risk patients might be underestimated when
only the general PICU population is examined.
Analyzing medical records from non-survivors with a
low risk of dying is an efficient tool to discover prob-
lems in the quality of care [14]. If low-risk PICU pa-
tients deteriorate or die because of preventable AEs,
there is a potential for improving their outcome.
The aim of this exploratory study was to study the
occurrence of AEs in the low-risk non-survivors (LNs),
compared to low-risk survivors (LSs), high-risk non-sur-
vivors (HNs), and high-risk survivors (HSs) in two
PICUs. Of all AEs, we studied the severity, preventabil-
ity, and nature. The study was designed as a retrospec-
tive exploratory study that used chart review to examine
the feasibility of detecting AEs in this patient group.
Methods
Study design and setting
This is a retrospective patient record study to measure the
occurrence of AEs in low-risk non-survivors and to compare
the results with patients with a different risk profile and dif-
ferent outcomes, using a random stratified sample of 48 re-
cords. The study was performed in two PICUs. Data collec-




2012 were stratified into four groups with different risk profiles
anddifferentoutcomes.ThestudygroupconsistedofLNs.Three
control groups were chosen: LSs, HNs, and HSs. Low-risk ad-
missions were defined as admissions with a mortality risk in the
simply recalibrated Pediatric Index of Mortality (PIM) 2 score
and/or recalibrated Pediatric Risk of Mortality II score (further
referred as BPRISM^) of < 1% [24, 25, 27, 29, 35]. High-risk
admissions were defined as admissions with a mortality risk in
the simply recalibrated PIM2 and/or PRISM of ≥ 30% [35].
Other inclusion criteria were the following: age < 18 years
and PICU length of stay of at least 2 h. Exclusion criteria were
the following: patients already deceased before admission (for
example, brain dead patients, admitted for organ donation),
corrected age < 36 weeks (gestational age), invalid or impos-
sible PIM2/PRISM score, and no clinical data available.
The mortality risk scores and PICU outcome data were
provided by the national PICU registry (Pediatric Intensive
Care Evaluation (PICE) registry) [23]. The PICE registry is
a national database containing anonymized information of ad-
mission characteristics, severity of illness, and patient out-
come. Data quality is assessed using standard procedures in-
cluding audit site visits. Of all patients, both PIM2 and PRISM
scores are collected. The models were recalibrated for the
study period to predict the overall mortality in the total popu-
lation in this period without altering the relative weights of
risk factors in the models and thus retaining the discriminative
power of the models [35, 37]. A local copy from the PICE
registry was sent to the local PICUs including all admissions
between 2006 and 2012. The database of these two PICUs
(total of 11,216 admissions: PICU-1, 8438 admissions;
PICU-2, 2778 admissions) contained 39 LNs.
Since the study was designed as an exploratory study, a se-
lection of roughly one third of the LN was used for the study.
Twelve LNs were selected for the study. Because the number of
patients between the two participating centers was unequal, nine
admissions from PICU-1 and three admissions from PICU-2
were selected for each study group, using a computer-based
research randomizer [34]. To avoid different population charac-
teristics, the patients in the control groups (LS (n = 12), HN (n =
12), HS (n = 12)) were stratified based on PICU center, gender,
and age category. After stratification, the patients were randomly
chosen using the computer-based research randomizer.
To verify if the risk profile of patients was correct, the PIM2
and PRISM scores were checked using available physiologic
and laboratory data. If a discrepancy was discovered, e.g., the
corrected mortality risk turned out to be >2% in LN and LS or
< 30% in HN and HS, the patient was excluded from the study.
The next from the list of available patients (with the same risk
group/outcome/PICU center/gender/age category) was selected
until, in each group, 12 patients were included.
Data collection
An established set of triggers was modified to local character-
istics of the PICU population and was used in a retrospective
chart review to discover AEs (Table 4, online only) [1]. In the
first stage, patient charts were manually reviewed for the pres-
ence of 19 triggers. In the second stage, each positive trigger
was followed by an in-depth investigation for the presence of
associated AEs. Both stages were performed by a pediatric
intensivist (CV) with more than 15 years of PICU experience
who was trained in the use of the trigger tool method.
Primary outcomes were the occurrence of AEs and AE rate
(AE/PICU day). For the AE rate, only AEs occurring during
the PICU admission were included. AEs that occurred shortly
before PICU admission and were beyond doubt related to the
PICU admission were scored as BAE pre PICU.^ The severity
of AEs was rated using the National Coordinating Council for
Medication Error Reporting and Prevention (NCC MERP)
Index for Categorizing Errors (Table 5, online only) [20].
Preventability of AEs was scored on a 6-point scale (Table
6, online only) [3]. AEs with a preventability score of 4–6
were defined as preventable. A preventable AE results from
an error in management due to failure to follow accepted prac-
tice at an individual or system level. Accepted practice was
taken to be Bthe current level of expected performance for the
average practitioner or system that manages the condition in
question^ [38]. AEs were grouped into eight categories, based
on the classification made by Hogan et al. (Table 7, online
only) [15]. If problems were encountered in AE determination
and categorizing AEs, a decision was taken after discussion
within the research group.
The ANZPIC registry diagnostic code list was used for diag-
nosis classification [30]. An admission was classified as having
a CCC or a non-complex chronic condition (NCCC) if either the
primary diagnosis, the primary underlying diagnosis, or the first
additional diagnosis was a diagnosis defined as a CCC or
NCCC according to a modified Feudtner’s list [5, 7, 8]. PICE
diagnoses not appearing on these lists were classified before
analyzing the data according to expert opinion (CV, JL) [35].
The list of the PICE database diagnoses grouped as a CCC and
NCCC is described in Table 8 and Table 9 (online only).
Socio-economic status of the family was obtained by cou-
pling the four digits of the postal code to the socio-economic
status of the neighborhood in 2006 (The Netherlands Institute
for Social Research) and grouped into three categories [32].
Data analysis
Normal distribution of continuous variables was tested using
sampling distributions and skewness and kurtosis tests. Not
normally distributed data were reported by median and inter-
quartile range (IQR). Non-parametric tests (Mann-Whitney
U) were used for the analyses of not normally distributed data.
Eur J Pediatr
For categorical variables, Fisher’s exact test or the chi-square
test was used (software: IBM SPSS Statistics 22).
Reliability study
To assess the reliability of the record review process, a random




A total of 48 patients were randomly selected. Nine admis-
sions were excluded, and therefore, nine new admissions were
chosen as described (Fig. 1, flowchart).
Patient characteristics are listed in Table 1. The four groups
were different on admission characteristics, mortality risk
scores, presence of CCCs, and outcome characteristics like
length of stay. The LN group had more medical admissions
and higher PRISM mortality risk compared to the LS group.
The PIM2 mortality risks between LN and LS were compara-
ble. LN patients were more often mechanically ventilated; had
more ventilator days, more central venous catheters, and more
central venous catheter days; and had a longer length of stay
compared to LS patients.
In the LN group, most patients had a CCC (not resulting in
a higher PIM2 or PRISM score) in contrast to the HN, where
CCCs occurred in a minority of patients. In the HN, cardio-
pulmonary resuscitation was a frequent reason for admission,
often resulting in brain death as the cause of death. In the
majority of the LN, patients died after limiting therapeutic
options. The length of stay in the LN was much longer com-
pared to the HN and also longer compared to the HS.
Adverse events
The occurrence of AEs in the LN group was significantly higher
compared to that in the LS and HN groups (Table 2). Eighty-
three percent of the LN patients suffered from at least one AE.
Twenty-five AEs occurred in the LN group. TheAE rate (AE per
PICU day) in the LN groupwas significantly higher compared to
that in the LS and HN groups (median 0.12 AE/PICU day).
In Table 3, preventability, severity, and classification of all
identified AEs are shown. In the LN group, eight preventable
AEs occurred. In five of these preventable AEs, the severity
was high (grade G-I). Two patients, in both the LN groups,
died after a preventable AE. Looking at all 15 preventable
AEs found among all subgroups in this study, most pre-
ventable AEs were related to problems in clinical mon-
itoring (n = 5), infection control (n = 5), and diagnosis
(n = 2). Detailed information about all patients with
AEs including description, timing, severity, and prevent-
ability of the AEs is shown in Table 10 (online only).
The day on which the AE occurred varied from day 0
(preceding the PICU admission) to the last days of the
PICU stay.
Fig. 1 Flowchart of the study
population. LN low-risk non-sur-
vivor, LS low-risk survivor, HN
high-risk non-survivor, HS high-
risk survivor, PIM2 Pediatric
Index of Mortality score, PRISM
Pediatric Risk of Mortality
Eur J Pediatr
Table 1 Patient characteristics
Characteristic LN LS HN HS
Patients in each subgroup 12 12 12 12
Gender: male 6 6 6 6
Age group
• 1–28 days 1 1 1 1
• 29–365 days 4 4 4 4
• 1–4 years 0 0 0 0
• 5–17 years 7 7 7 7
Age: median [IQR] (years) 9.5 [0–12.8] 7.5 [0–13.0] 5.0 [0–13.3] 5.5 [0–11.3]
Weight: median [IQR] (kg) 32.5 [3.9–53.5] 14.9 [3.1–44.8] 20.0 [7.0–50.0] 22.0 [5.5–37.0]
Socio-economic status
• Low 3 3 2 3
• Intermediate 5 8 8 8
• High 3 1 1 1
• Unknown 1 0 1 0
Non-elective admission 10 7d,f 12 12
Medical admission 12aa,c 6 8 10
CPR or brain herniation as the cause for PICU admission 0 0 9b 3
Off-hours admission 6 4 6 7
Chronic condition
• CCC 9cc 7 3b 6
• NCCC 2 1 0 3
• None 1 4 9 3
Recalibrated PRISM mortality risk, median [IQR] (%) 0.9 [0.7–1.4]a,ccc,eee 0.6 [0.5–0.8]ddd,fff 77.0 [21.4–87.4] 43.6 [35.3–60.5]
Recalibrated PIM2 mortality risk, median [IQR] (%) 1.3 [0.8–6.1]ccc,e 1.3 [1.0–2.2]d,fff 56.1 [21.8–83.4]b 14 [14–46]
Mechanical ventilation 11aa 4dd,ff 12 12
Ventilator days, median [IQR] 6.5 [2.5–30.8]aaa 0 [0–1.8]ddd,ff 2.5 [1.0–9.3] 6.5 [4.3–11.5]
Central venous catheter 10a 5ff 11 9
Central venous catheter days, median [IQR] 4.5 [1.3–14.3]aa 0 [0–2]dd,ff 2.5 [1–17.5] 6.5 [1–11.8]
Extracorporal life support 2* 0 1 3
Length of stay, median [IQR] (days) 16 [5.5–32.8]aa,c,e 2 [2–2.8]dd 2.5 [1–9.3]b 11 [6.3–13]
Mode of death (n = 24) Not applicable Not applicable
- Brain death 0c 6
- Maximal treatment including CPR 1 0
- Maximal treatment without CPR 2 1
- Limiting or withdrawal of therapy 9 5
All numbers are expressed as the number of patients unless specified otherwise
LN low-risk non-survivors, LS low-risk survivors, HN high-risk non-survivors, HS high-risk survivors
* Two patients in LNwith extracorporal life support (ECLS): one patient, a neonate with a very complex congenital cardiac disorder including pulmonary
atresia and total abnormal pulmonary venous return, was admitted preoperatively for cardiac surgery and needed ECLS after surgery but did not survive.
The mortality risk in this patient was—according to the PIM2/PRISM criteria—measured before surgery and was low. Another patient, admitted with
severe asthma, was resuscitated during PICU stay (day 2) and supported by ECLS after resuscitation but died of cerebral post-anoxic complications
a p < 0.05, aa p < 0.01, and aaa p < 0.001, LN compared with LS; b p < 0.05, HN compared with HS; c p < 0.05, cc p < 0.01, and ccc p < 0.001, LN compared
with HN; d p < 0.05, dd p < 0.01, and ddd p < 0.001, LS compared with group HS; e p < 0.05, and eee p < 0.001, LN compared with group HS; f p < 0.05,
ff p < 0.01, and fff p < 0.001, LS compared with group HN
Table 2 Adverse events
Outcome measure LN LS HN HS
Patients with ≥ 1 AE(/n) 10/12aaa,cc 1/12dd 2/12b 7/12
AE PICU/PICU day, median [IQR] 0.12 [0.07–0.29]aaa,cc 0 [0–0]dd 0 [0–0]b 0.03 [0.0–0.17]
Number of AEs, total 25 2 8 10
Number of AEs/patient, median [IQR] 2 [1–3.8] 0 [0–0] 0 [0–0] 1 [0–1]
Only the primary outcome (patients with greater than or equal to one AE) and AE rate were tested
LN low-risk non-survivors, LS low-risk survivors, HN high-risk non-survivors,HS high-risk survivors, AE adverse event, PICU pediatric intensive care
unit, AE PICU/PICU day the number of AEs per patient day
aaa p < 0.001, LN comparedwith LS; b p < 0.05, HN compared with HS; cc p < 0.01, LN comparedwith HN; dd p < 0.01, LS compared with group HS, LN
compared with group HS; f p < 0.05, ff p < 0.01, and fff p < 0.001, LS compared with group HN
Eur J Pediatr
Inter-observer agreement
Nine patient records were reviewed by the second investiga-
tor. Inter-observer agreement was 8/9 (89%).
Discussion
Major findings
In this exploratory study, AEs occurred in 83% of the LN. The
occurrence of AEs and AE rate in these LN patients were
significantly higher compared to those in LS patients and also
higher compared to those in HN patients. A substantial part of
the AEs in the LN group was preventable and had severe
consequences, including two LN patients who died after a
preventable AE. Screening patients with a low mortality risk
is a valuable tool to discover problems in the quality of care
and might reduce preventable death by implementing targeted
quality improvement measures.
A possible explanation for the higher occurrence of AEs in
the LN group might be that Blow-risk^ as defined by a calcu-
lated low mortality risk does not always reflect a true low risk
of dying. Mortality risk scores such as PIM2 or PRISM scores
perform reasonably well for the PICU population in general
with an AUC between 0.83 and 0.90 but not for each individ-
ual [37]. Many patients in the LN group are sicker than they
appear based on the PIM2 or PRISM score. Misclassifications
do occur. For example, seven LN patients were admitted to the
PICU with major comorbidity such as hemato-oncology
Table 3 Preventability, severity, and classification of adverse events
Group No AEs Preventability Severity Classification
LN 25 8 preventable AEs I = 2 Infection control = 1
Clinical monitoring = 1
G–H = 3 Drug or fluid related = 1
Diagnosis = 2
E–F = 3 Infection control = 2
Clinical monitoring = 1
17 non-preventable AEs I = 4 Other = 3
Drug or fluid related = 1
G–H = 5 Other = 4
Drug or fluid related = 1
E–F = 8 Infection control = 4
Other = 3
Technical = 1
LS 2 2 preventable AEs H = 2 Infection control = 1
Drug or fluid related = 1
HN 8 2 preventable AEs G–H = 1 Clinical monitoring = 1
E–F = 1 Infection control = 1
6 non-preventable AEs I = 1 ECLS = 1
G–H = 1 ECLS = 1
E–F = 4 ECLS = 1
Other = 3
HS 10 3 preventable AEs G–H = 1 ECLS = 1
E–F = 2 ECLS = 1
Clinical monitoring = 1
7 non-preventable AEs G–H = 5 Clinical monitoring = 1
ECLS = 1
Other = 3
E–F = 2 ECLS = 1
Technical = 1
Total 45 15 preventable Clinical monitoring = 4
30 unpreventable Diagnosis = 2
Drug or fluid related = 2
ECLS = 2
Infection control = 5
Clinical monitoring = 1
Drug or fluid related = 2
Technical = 2
ECLS = 5
Infection control = 4
Other = 16
Severity categories: E = contributed to or resulted in temporary harm to the patient and required intervention, F = contributed to or resulted in temporary
harm to the patients and required initial or prolonged hospitalization, G = contributed to or resulted in permanent patient harm, H = required intervention
to sustain life, I = contributed to or resulted in the patient’s death
LN low-risk non-survivors, LS low-risk survivors,HN high-risk non-survivors,HS high-risk survivors,AE adverse event, ECLS extracorporal life support
Eur J Pediatr
patients and patients with complex congenital heart disorder.
These low-risk patients with a CCC are often at high risk for
AEs [35]. Patients with congenital heart disorders are some-
times admitted preoperatively to the PICU. Mortality risk
scores can be obtained before surgery and do not measure true
postoperative risk. New PRISM methods like PRISM IV
might reflect mortality risk better in these patients because
the risk score is measured after surgery [26]. However, severe
and preventable AEs did occur in patients with and without a
CCC, so to our opinion, this is not the only explanation.
Comparing the AE rate from this study with other studies is
difficult because in this exploratory study, we did not include the
general PICU population but focused on the low- and high-risk
groups. A single PICU study on patient safety factors in 47 PICU
non-survivorsfoundthat36%ofnon-survivorssufferedat leastone
AEof category I and60%sufferedaBcritical incident^ [19].These
results cannot be compared with our study not only because of
different population characteristics but also due to different out-
come measures. The Bcritical incidents^ used in the study of
Monroe could either be AEs or medical errors not causing harm
(categoriesB–D), a categorywhich is toowide inouropinion [21].
From the viewpoint of quality improvement, preventable
AEs are the most interesting. Looking at the nature of the 15
preventable AEs found in this study, problems in clinical mon-
itoring (n = 5), infection control (n = 5), and diagnosis (n = 2)
were most prevalent. For example, a pediatric early warning
system might lead to timely recognition of deterioration and
thus lead to lower mortality [11]. During the study period,
pediatric early warning systems and sepsis bundles were im-
plemented in the participating hospitals, but the effectiveness
could not be systematically examined yet.
The length of stay in the LN group was significantly longer
compared to that in all other groups. A longer duration of stay
may be the consequence of the AEs or might have contributed
to an increased chance for AEs, and this cannot be estimated
from this retrospective study.
Limitations
Our studyhas several limitations.First, children in the agegroupof
1–4 years were not present in the randomly chosen LN group and
therefore not in the other groups, possibly giving rise to bias.
Second, a relatively high number of admissions were excluded
from the study. The decision to exclude patients was made on
predefined criteria. Remarkably, in seven patients, the PIM2/
PRISM score turned out to be false after verifying with the data
from themedical record.This should encouragebetter surveillance
of the database. Third, poor quality of the information in patient
records might lead to underestimation of the number of AEs. The
assessment ofAEswith a trigger toolmethod depends on the pres-
ence of data in the medical record. However, in a patient record
review study in Dutch hospitals, poor quality of the information
present in the medical record was associated with higher rates of
AEs[40].Anotherweaknessofall retrospectivestudies ishindsight
bias [9, 39].Knowledge of the final outcomemayhave influenced
judgmentonseverityandpreventability.Thiscould lead toanover-
estimationofpreventablesevereAEsasjudgedbytheinvestigators.
Finally, the mortality prediction models do not perform perfectly.
However, we found that both in real LN and in LN with a CCC,
severeAEs andAEs contributing to death occur.
Conclusion
This exploratory study shows that AEs do occur in PICU low-
risk non-survivors. The occurrence of AEs in low-risk non-sur-
vivors was higher compared to that in low-risk survivors and
high-risk non-survivors. Some AEs were severe and preventable
and contributed to morbidity and mortality. The exact scale and
nature of this safety problem should be analyzed in a largermulti-
center study.
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